کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
4211785 1280651 2010 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Reliability and validity of the clinical COPD questionniare and chronic respiratory questionnaire
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی پزشکی ریوی و تنفسی
پیش نمایش صفحه اول مقاله
Reliability and validity of the clinical COPD questionniare and chronic respiratory questionnaire
چکیده انگلیسی

SummaryBackgroundQuestionnaires are often used in assessing health-related quality of life in patients with chronic obstructive pulmonary disease (COPD). It is important that these questionnaires have good reliability, validity, and responsiveness. The aim of this study was to investigate and compare these properties in the disease specific Clinical COPD Questionnaire (CCQ) and the Chronic Respiratory Questionnaire self-reported (CRQ-SR).MethodsTwo hundred ninety six participants with spirometry confirmed mild to moderate COPD were included in a smoking cessation trial. It was assumed that health-related quality of life would improve in participants who stopped smoking. The questionnaires were administered at baseline and at weeks 5, 26, and 52 after the target quit date.ResultsAt baseline, 292 (97%) participants returned the CCQ and 296 (100%) the CRQ-SR questionnaire. For both instruments, the internal consistency was good (Cronbach’s alpha >70%) as was the convergent validity with each other but not with spirometry. The CCQ was responsive to improvements in respiratory symptoms at both week 26 (−1.02, SD = 0.81) and 52 (−1.04, SD = 0.91) and in the total score at week 26 (−0.54, SD = 0.50) and 52 (−0.43, SD = 0.44). The mastery domain and the total score of the CRQ-SR were responsive at week 26 (1.14, SD = 0.82; 0.67, SD = 0.97 respectively) but not at week 52 (0.04, SD = 0.93; 0.38, SD = 0.57 respectively).ConclusionBoth the CCQ and CRQ-SR are equally reliable and valid. The long-term responsiveness of the CCQ is better. Both questionnaires can be used in future studies involving patients with mild to moderate COPD. However, when the follow-up exceeds 26 weeks, the CCQ is the recommended alternative.Netherlands Trial Register: ISRCTN 64481813.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Respiratory Medicine - Volume 104, Issue 11, November 2010, Pages 1675–1682
نویسندگان
, , , , ,